Alisha Silvia Mercedes Hall

Alisha Silvia Mercedes Hall

Auto-generated profile, based on publicly available information

Alisha Silvia Mercedes Hall

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
FSFabian . Streit
Fabian . Streit
SASwapnil Awasthi
Swapnil Awasthi
AHAlisha Sm Hall
Alisha Sm Hall
ABAlice Braun
Alice Braun
MNMaria Niarchou
Maria Niarchou
NAN A
N A
We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.

14 October 2024 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
JMJessica Mundy
Jessica Mundy
AHAlisha S. M. Hall
Alisha S. M. Hall
JSJette Steinbach
Jette Steinbach
CAClara Albinaña
Clara Albinaña
EAEsben Agerbo
Esben Agerbo
KMKatherine L. Musliner
Katherine L. Musliner
Background: The clinical course of major depressive disorder (MDD) is heterogeneous, and early-onset MDD often has a more severe and complex clinical course. Our goal was to determine whether polygenic scores (PGSs) for psychiatric disorders are associated with treatment trajectories in early-onset MDD treated in secondary care.Methods: Data were drawn from the iPSYCH2015 sample, which includes all individuals born in Denmark between 1981 and 2008 who were treated in secondary care for depression between 1995 and 2015. We selected unrelated individuals of European ancestry with an MDD diagnosis between ages 10–25 (N = 10577). Seven-year trajectories of hospital contacts for depression were modeled using Latent Class Growth Analysis. Associations between PGS for MDD, bipolar disorder, schizophrenia, ADHD, and anorexia and trajectories of MDD contacts were modeled using multinomial logistic regressions.Results: We identified four trajectory patterns: brief contact (65%), prolonged initial contact (20%), later re-entry (8%), and persistent contact (7%). Relative to the brief contact trajectory, higher PGS for ADHD was associated with a decreased odds of membership in the prolonged initial contact (odds ratio = 1.06, 95% confidence interval = 1.01–1.11) and persistent contact (1.12, 1.03–1.21) trajectories, while PGS-AN was associated with increased odds of membership in the persistent contact trajectory (1.12, 1.03–1.21).Conclusions: We found significant associations between polygenic liabilities for psychiatric disorders and treatment trajectories in patients with secondary-treated early-onset MDD. These findings help elucidate the relationship between a patient's genetics and their clinical course; however, the effect sizes are small and therefore unlikely to have predictive value in clinical settings.

2 September 2026 in Nature
Verified
Journal Article
Open access
PDF file
TSTed Schwaba
Ted Schwaba
MSMargaret L. Clapp Sullivan
Margaret L. Clapp Sullivan
WAWonuola A. Akingbuwa
Wonuola A. Akingbuwa
KIKerli Ilves
Kerli Ilves
PTPeter T. Tanksley
Peter T. Tanksley
ETElliot M. Tucker-Drob
Elliot M. Tucker-Drob
Personality traits describe stable differences in how people think, feel and behave, and how they interact with and experience their social and physical environments1,2. Many questions remain unanswered about associations between DNA and personality traits, such as their robustness, their generalizability and the biological and social pathways through which they act. Here we meta-analyse data across 46 cohorts comprising 611,037 to 1.14 million participants with European-like and African-like genomes for genome-wide association studies (GWAS) of the Big Five personality traits (extraversion, agreeableness, conscientiousness, neuroticism and openness to experience), and data from up to 50,725 participants for within-family GWAS. We identify 1,260 lead genetic variants associated with personality, including 824 novel variants3. Common genetic variants explain a moderate 4.8–9.3% of the variance in measures of each trait, and 9.3–13.3% among instruments with typical measurement reliability. Genetic associations with personality are highly consistent but not identical across geography, reporter (self versus close other), age group and measurement instrument, and we find minimal spousal assortment for personality in recent history. In contrast to many other social and behavioural traits4,5, within-family GWAS and polygenic index analyses indicate that genetic associations with personality are minimally confounded by the shared family environment. Polygenic prediction, genetic correlation and Mendelian randomization analyses indicate that personality traits have widespread, potentially causal associations with consequential behaviours and life outcomes. Overall, we find that the genetic architecture of personality is robustly generalizable, minimally confounded and widely relevant to human experience.

2 January 2025 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Open access
JMJessica Mundy
Jessica Mundy
AHAlisha S. M. Hall
Alisha S. M. Hall
EAEsben Agerbo
Esben Agerbo
CAClara Albiñana
Clara Albiñana
JSJette Steinbach
Jette Steinbach
KMKatherine L. Musliner
Katherine L. Musliner
Background: Previous research has shown that females who use hormonal contraception are at increased risk of developing depression, and that the risk is highest among adolescents. While this finding could reflect age‐specific effects of exogenous hormones on mental health, genetic liability for mental disorders could be confounding the association. Our goal was to test the plausibility of this hypothesis by determining whether polygenic liabilities for major depressive disorder (MDD), bipolar disorder (BD), schizophrenia (SCZ), and attention deficit hyperactivity disorder (ADHD) are associated with younger age at hormonal contraception initiation.Methods: We conducted a cohort study using data from the Danish iPSYCH2015 sub‐cohort, a representative sample of people born in Denmark between May 1981 and December 2008. Polygenic scores (PGSs) for MDD, BD, SCZ, and ADHD were created using the most recent genome‐wide association study meta‐analyses from the Psychiatric Genomics Consortium. Associations between PGSs and hormonal contraception initiation in the following age categories: 10–14, 15–19, 20–24, and 25+ were examined via Cox regression. We examined any hormonal contraception, oral contraception, and non‐oral contraception.Results: PGS‐MDD and PGS‐ADHD showed the strongest associations with hormonal contraception initiation at age 10–14 (PGS‐ADHD: HR = 1.21 [95% CI = 1.16–1.27], p = 6.16 x 10−18; PGS‐MDD: 1.21 [1.16–1.27], p = 1.22 x 10−17). The associations then steadily decreased as age at hormonal contraception initiation increased. Both PGS‐MDD and PGS‐ADHD were also associated with initiation at ages 15–19, but not at 20–24 or 25+. PGS‐BD and PGS‐SCZ were also associated, albeit not as strongly, with initiation at age 10–14 only (PGS‐BD: 1.07 [1.02–1.13], p = 6.87 × 10−3; PGS‐SCZ: 1.09 [1.04–1.14], p = 8.61 × 10−4).Conclusions and Relevance: These results suggest that genetic confounding could explain some of the association between early hormonal contraception use and depression. Where possible, researchers studying this important topic should account for possible confounding by genetic liability for mental disorders.

20 July 2026 in Nature Genetics
Verified
Journal Article
Open access
PDF file
FSFabian . Streit
Fabian . Streit
SASwapnil Awasthi
Swapnil Awasthi
AHAlisha S. M. Hall
Alisha S. M. Hall
ABAlice Braun
Alice Braun
MNMaria Niarchou
Maria Niarchou
SWStephanie Witt
Stephanie Witt
Borderline personality disorder (BPD) is a severe mental health condition influenced by environmental risk factors (for example, interpersonal trauma) and genetic factors. We conducted the largest genome-wide association study (GWAS) meta-analysis of BPD so far, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci and 9 risk genes in gene-based analyses. We observed a single-nucleotide polymorphism heritability of 17.3% and derived polygenic scores (PGS) that predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of post-traumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide analyses in Vanderbilt University Medical Center Biobank and UK Biobank using BPD-PGS confirmed these associations and also identified associations with other medical conditions, including obstructive pulmonary disease and diabetes. These analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.

10 April 2026 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
AHAlisha S. M. Hall
Alisha S. M. Hall
KMKatherine L. Musliner
Katherine L. Musliner
JDJean-Christophe P. Debost
Jean-Christophe P. Debost
BVBjarni J. Vilhjálmsson
Bjarni J. Vilhjálmsson
ZCZheng Chang
Zheng Chang
IBIsabell Brikell
Isabell Brikell
Borderline personality disorder (BPD) often co-occurs with other health conditions, but the role of genetics vs. environment is unclear. In this multigenerational cohort study using Swedish national registers, the authors quantified the co-aggregation of BPD with other phenotypes in families and estimated the genetic vs. environmental contributions. In a birth cohort of individuals born 1973–2001 and their twins, siblings, cousins, parents, and aunts/uncles, the exposure was BPD in the proband. Odds ratios were estimated for 19 psychiatric, 18 somatic, and seven behavioral/injury outcome phenotypes within individuals and relative pairs. Structural equation modeling was used to estimate genetic, common environmental, and unique environmental contributions to phenotypic associations and genetic correlations ( r g ). Of the 2.7 million individuals in the birth cohort (mean age at follow-up end = 31.7 years, SD = 9.8, 48.5% female), 24,547 (86% female) were diagnosed with BPD by follow-up end. Relatives of individuals with BPD had increased risk for various psychiatric, somatic, and behavioral phenotypes, except cystic fibrosis. Psychiatric phenotypes showed the strongest phenotypic and genetic correlations, with equal contributions from genetic and unique environmental factors. The pattern varied for somatic phenotypes, which also had weaker correlations. Sleep disorders showed the strongest genetic overlap with BPD ( r g = 0.74, 95%CI = 0.39–1.08). Behavioral phenotypes related to BPD symptoms showed strong associations and genetic overlap ( e.g ., self-harm r g = 0.80, 95%CI = 0.55–1.04), whereas accident-related phenotypes had weaker associations and varied genetic/environmental contributions. BPD co-aggregates with many phenotypes, with psychiatric conditions showing the strongest genetic overlap. These findings guide further research on BPD comorbidity causes and interventions.